Coronavirus Outbreaks Linked To Recently Switched Influenza Vaccination Launched by Wuhan Biological Warfare Research Facility

Jan. 24, 2020
Immunization provides the best protection against the influenza virus and vaccines have been available for decades with a recent switch from trivalent to quadrivalent vaccines that protect against each two influenza type A and two B strains.

The late stage pipeline for seasonal influenza vaccines in the 3GM includes the first quadrivalent seasonal influenza vaccines in China from Sinovac, Chongqing Zhifei, and Wuhan, as well as a quadrivalent formulation of Fluad.Quadrivalent live-attenuated vaccines will launch in India (from the Serum Institute) and Japan (AstraZeneca’s FluMist, licensed by Daiichi Sankyo).

[link to www.ptcommunity.com (secure)]

“The launch of the first inactivated quadrivalent influenza vaccines in China from Sinovac Biotech, Chongqing Zhifei Biological Products and Wuhan Institute of Biological Products"

[link to www.europeanpharmaceuticalreview.com (secure)]

January 24, 2020
Virus-hit Wuhan has two laboratories linked to Chinese bio-warfare program

[link to m.washingtontimes.com (secure)]

Thread: Virus-hit Wuhan has two laboratories linked to Chinese bio-warfare program

26 January 2020
In 1993, China declared a second facility, the Wuhan Institute of Biological Products, as one of eight biological warfare research facilities covered by the Biological Weapons Convention (BWC) which China joined in 1985.

[link to www.outlookindia.com (secure)]

13 hours ago
According to figures compiled by the Center for Systems Science and Engineering, Johns Hopkins University, as of mid-Tuesday morning Beijing time, 4,474 cases of the coronavirus had been confirmed in mainland China, and 107 deaths had been recorded, the vast majority in Hubei province.

[link to cnsnews.com (secure)]

Conclusion;
Recently switched Influenza Vaccination was launched by Wuhan Institute of Biological Products and is also a biological warfare research facility.